Parkinson’s Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response

Parkinson’s Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response

Background. It is known that ultra-low doses of haloperidol can cause dopamine supersensitivity of dopamine D2 receptors and related behaviour in animals. Objective. The objective was to determine whether a daily ultra-low dose of 40 micrograms of haloperidol could enhance the clinical action of lev...

Full description

Bibliographic Details
Main Authors:	Craig J. Hudson, Philip Seeman, Mary V. Seeman
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2014/684973

Similar Items

Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization
by: Wang Min, et al.
Published: (2010-09-01)

Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
by: Luyu Fan, et al.
Published: (2020-02-01)

Haloperidol effects on striatal dopamine and DOPAC levels and subcellular distribution
by: Wallace Lane J
Published: (2012-07-01)

The exchange of sodium and potassium in salivary glands.
by: Seeman, Philip.
Published: (1956)

Travel Risks for Those With Serious Mental Illness
by: Mary Seeman
Published: (2016-09-01)

Dopamine Receptor Gene Expression Changes in Peripheral Blood Mononuclear Cells from Schizophrenic Patients Treated with Haloperidol and Olanzapine
by: G.H. Shariati, et al.
Published: (2009-05-01)

Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson’s disease
by: Atul Kabra, et al.
Published: (2020-10-01)

Feasibility of Obtaining Sufficient Numbers of Responses to Questions About Travel Intentions, Thereby Facilitating Effective Health Messaging
by: Neil Seeman, et al.
Published: (2019-06-01)

Conditioned increase of locomotor activity induced by haloperidol.
by: Luis Gonzalo De la Casa, et al.
Published: (2018-01-01)

Sex‐dependent alterations of dopamine receptor and glucose transporter density in rat hypothalamus under long‐term clozapine and haloperidol medication
by: Marie‐Luise Bouvier, et al.
Published: (2020-08-01)

Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease
by: Bergsland Maria, et al.
Published: (2009-12-01)

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s disease
by: Joyce P.M. van der Vegt, et al.
Published: (2020-01-01)

Effects of dopamine on sensitivity to social bias in Parkinson's disease.
by: Atbin Djamshidian, et al.
Published: (2012-01-01)

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
by: Luca Magistrelli, et al.
Published: (2021-04-01)

Haloperidol interferes with the impact of rewarding and aversive stimuli: Re-appraisal of the anhedonia hypothesis of dopamine blocking
by: Andrew Chih Wei Huang, et al.
Published: (2003)

Adolescent Nicotine Sensitization and Effects of Nicotine on Accumbal Dopamine Release in a Rodent Model of Increased Dopamine D2 Receptor Sensitivity
by: Perna, Marla K., et al.
Published: (2013)

Assessing the Effects of Antipsychotics on Parenting
by: Mary V. Seeman
Published: (2018-01-01)

Why Are Women Prone to Restless Legs Syndrome?
by: Mary V. Seeman
Published: (2020-01-01)

Intervention to Prevent Child Custody Loss in Mothers with Schizophrenia
by: Mary V. Seeman
Published: (2012-01-01)

The Pharmacodynamics of Antipsychotic Drugs in Women and Men
by: Mary V. Seeman
Published: (2021-04-01)

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D<sub>3 </sub>receptor
by: Borwege Sabine, et al.
Published: (2004-10-01)

Addressing Delusions in Women and Men with Delusional Disorder: Key Points for Clinical Management
by: Alexandre González-Rodríguez, et al.
Published: (2020-06-01)

DOUBLE DISSOCIATION OF THE EFFECTS OF HALOPERIDOL AND THE DOPAMINE D3 RECEPTOR-SPECIFIC ANTAGONIST ABT-127 ON ACQUISITION VS. EXPRESSION OF COCAINE CONDITIONED ACTIVITY
by: Banasikowski, Tomek J,
Published: (2007)

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats
by: Víctor Fernández-Dueñas, et al.
Published: (2015-01-01)

Genetic basis of haloperidol resistance in Saccharomyces cerevisiae is complex and dose dependent.
by: Xin Wang, et al.
Published: (2014-12-01)

Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
by: Noham Wolpe, et al.
Published: (2018-10-01)

Treatment of first episode schizophrenia with low-dose haloperidol : a study in the Western Cape Province of South Africa
by: Oosthuizen, P. P. (Petrus Paulus)
Published: (2012)

Estradiol increases the sensitivity of ventral tegmental area dopamine neurons to dopamine and ethanol.
by: Bertha J Vandegrift, et al.
Published: (2017-01-01)

The Working Hours of Ants
by: Ernest Seeman
Published: (1928-01-01)

Growth and Age-Related Abnormalities in Cortical Structure and Fracture Risk
by: Ego Seeman
Published: (2015-12-01)

Dietary-medical-psychological implications of ketogenic diet
by: Seeman, Anne
Published: (2011)

A Case Study of Cross-ownership Waivers: Framing Newspaper Coverage of Rupert Murdoch’s Requests to Keep <i>The New York Post</i>
by: Seeman, Rachel
Published: (2009)

Gender-Specific Differences in Low-Dose Haloperidol Response for Prevention of Postoperative Nausea and Vomiting: A Register-Based Cohort Study.
by: Florian Brettner, et al.
Published: (2016-01-01)

Advances and Unmet Needs in the Therapeutics of Bone Fragility
by: Sabashini K. Ramchand, et al.
Published: (2018-09-01)

Haloperidol in palliative care: Indications and risks
by: Iwona Zaporowska-Stachowiak, et al.
Published: (2020-12-01)

Persistent Oral Dyskinesias Induced by Long-term Haloperidol Treatment is Dissociated from Changes in Neostriatal B(max) and Mrna Content for Dopamine D(2) Receptors
by: Huang, Nuoyu
Published: (1995)

Genetische Assoziationsstudie des Dopamin 2 Rezeptorgens und des ANKK1 Gens zum Ansprechverhalten auf Haloperidol
by: Krämer, Philipp
Published: (2011)

Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole
by: M. R. Nodel
Published: (2011-12-01)

Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease
by: S N Illarioshkin
Published: (2012-06-01)

Striatal dopamine receptor sensitivity and circling behaviour in the rat
by: Kelly, M. E.
Published: (1983)